Drug Details |  |
Name: | Darifenacin |  |
---|
PubChem ID: | 444031 |
---|
Pathway: | Show KEGG pathways |
---|
InChI: | InChI=1/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1/f/h29H2
|
---|
SMILES: | c1ccc(cc1)C(c1ccccc1)([C@@H]1(CCN(CCc2ccc3c(CCO3)c2)C1))C(N)=O |
---|
|
Properties: | Formula: | C28H30N2O2 | Atoms: | 33 |
---|
Molecular Weight: | 426.55 | Rotatable Bonds: | 7 |
---|
H-bond Acceptors: | 4 | H-bond Donors: | 0 |
---|
logP: | 4.5957 | | |
---|
|
---|
Targets: | |
---|
Synonyms: | 133099-04-4 | 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-di(phenyl)acetamide | 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-dip | CHEBI:391960 | D03654 | Darifenacin | Darifenacin (USAN/INN) | DB00496 | Emselex | Enablex | LS-187359 | NCGC00168775-01 |
|
---|
ATC-Codes: | |
---|
Side-Effects: | Side-Effect | Frequency |
---|
palpitations | 0.0010 | hallucinations | 0.0010 | hypersensitivity | 0.0010 | confusion | 0.0010 | angioedema | 0.0010 | rhinitis | 0 | tachycardia | 0 | sweating | 0 | cerebrovascular accident | 0 | pharyngitis | 0 | pruritus | 0 | ulcerative stomatitis | 0 | sinusitis | 0 | urinary tract infection | 0 | vaginitis | 0 | dry eyes | 0 | thinking abnormal | 0 | dry skin | 0 | sgot increased | 0 | peripheral edema | 0 | urinary retention | 0 | dry mouth | 0 | weight gain | 0 | vomiting | 0 | abnormal vision | 0 | insomnia | 0 | pain | 0 | nausea | 0 | dizziness | 0 | diarrhea | 0 | cough | 0 | constipation | 0 | bronchitis | 0 | benign prostatic hyperplasia | 0 | back pain | 0 | asthenia | 0 | arthralgia | 0 | somnolence | 0 | dyspepsia | 0 | irritability | 0 | irritable bowel syndrome | 0 | influenza | 0 | impotence | 0 | hypertension | 0 | headache | 0 | flatulence | 0 | rash | 0 | edema | 0 | abdominal pain | 0 |
|
---|